1. Home
  2. SQNS vs ACOG Comparison

SQNS vs ACOG Comparison

Compare SQNS & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQNS
  • ACOG
  • Stock Information
  • Founded
  • SQNS 2003
  • ACOG 2000
  • Country
  • SQNS France
  • ACOG Canada
  • Employees
  • SQNS N/A
  • ACOG N/A
  • Industry
  • SQNS Semiconductors
  • ACOG
  • Sector
  • SQNS Technology
  • ACOG
  • Exchange
  • SQNS Nasdaq
  • ACOG Nasdaq
  • Market Cap
  • SQNS 124.0M
  • ACOG 129.6M
  • IPO Year
  • SQNS 2011
  • ACOG N/A
  • Fundamental
  • Price
  • SQNS $8.56
  • ACOG $6.98
  • Analyst Decision
  • SQNS Buy
  • ACOG Strong Buy
  • Analyst Count
  • SQNS 1
  • ACOG 1
  • Target Price
  • SQNS $35.00
  • ACOG $20.00
  • AVG Volume (30 Days)
  • SQNS 355.4K
  • ACOG 97.8K
  • Earning Date
  • SQNS 11-04-2025
  • ACOG 11-14-2025
  • Dividend Yield
  • SQNS N/A
  • ACOG N/A
  • EPS Growth
  • SQNS N/A
  • ACOG N/A
  • EPS
  • SQNS 18.54
  • ACOG N/A
  • Revenue
  • SQNS $37,325,000.00
  • ACOG $4,586,341.00
  • Revenue This Year
  • SQNS N/A
  • ACOG N/A
  • Revenue Next Year
  • SQNS $89.05
  • ACOG $149.89
  • P/E Ratio
  • SQNS $0.47
  • ACOG N/A
  • Revenue Growth
  • SQNS 32.07
  • ACOG N/A
  • 52 Week Low
  • SQNS $7.30
  • ACOG $3.75
  • 52 Week High
  • SQNS $58.30
  • ACOG $11.54
  • Technical
  • Relative Strength Index (RSI)
  • SQNS 58.43
  • ACOG 39.26
  • Support Level
  • SQNS $9.40
  • ACOG $6.80
  • Resistance Level
  • SQNS $9.74
  • ACOG $7.80
  • Average True Range (ATR)
  • SQNS 0.54
  • ACOG 0.57
  • MACD
  • SQNS -0.40
  • ACOG -0.00
  • Stochastic Oscillator
  • SQNS 3.55
  • ACOG 40.12

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: